These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Fluvastatin prevents vascular hyperplasia by inhibiting phenotype modulation and proliferation through extracellular signal-regulated kinase 1 and 2 and p38 mitogen-activated protein kinase inactivation in organ-cultured artery. Sakamoto K, Murata T, Chuma H, Hori M, Ozaki H. Arterioscler Thromb Vasc Biol; 2005 Feb; 25(2):327-33. PubMed ID: 15591221 [Abstract] [Full Text] [Related]
5. Relaxant effect of 6-deoxyclitoriacetal on smooth muscle preparations. Itthipanichpong C, Ruangrungsi N, Saibundasak K. J Med Assoc Thai; 2001 Jun; 84 Suppl 1():S208-15. PubMed ID: 11529336 [Abstract] [Full Text] [Related]
6. Unrepeatable extracellular Ca2+-dependent contractile effects of cyclopiazonic acid in rat vascular smooth muscle. Zhang WB, Kwan CY. Eur J Pharmacol; 2009 May 21; 610(1-3):81-6. PubMed ID: 19292983 [Abstract] [Full Text] [Related]
7. Role of C-terminal amidation on the biological activity of neurokinin A derivatives with agonist and antagonist properties. Patacchini R, Quartara L, Rovero P, Goso C, Maggi CA. J Pharmacol Exp Ther; 1993 Jan 21; 264(1):17-21. PubMed ID: 8380857 [Abstract] [Full Text] [Related]
9. Pharmacological characterization of FK1052, a dihydropyridoindole derivative, as a new serotonin 3 and 4 dual receptor antagonist. Nagakura Y, Kadowaki M, Tokoro K, Tomoi M, Mori J, Kohsaka M. J Pharmacol Exp Ther; 1993 May 21; 265(2):752-8. PubMed ID: 8496821 [Abstract] [Full Text] [Related]
12. Benzofuroindole analogues as potent BK(Ca) channel openers. Gormemis AE, Ha TS, Im I, Jung KY, Lee JY, Park CS, Kim YC. Chembiochem; 2005 Oct 21; 6(10):1745-8. PubMed ID: 16149102 [No Abstract] [Full Text] [Related]
13. Studies on peripheral actions of isatin. Hota D, Acharya SB. Indian J Exp Biol; 1994 Oct 21; 32(10):710-7. PubMed ID: 7821981 [Abstract] [Full Text] [Related]
14. Anxiolytic-like effect of a serotonergic ligand with high affinity for 5-HT1A, 5-HT2A and 5-HT3 receptors. Delgado M, Caicoya AG, Greciano V, Benhamú B, López-Rodríguez ML, Fernández-Alfonso MS, Pozo MA, Manzanares J, Fuentes JA. Eur J Pharmacol; 2005 Mar 21; 511(1):9-19. PubMed ID: 15777774 [Abstract] [Full Text] [Related]
15. Comparison of 5-HT4 and 5-HT7 receptor expression and function in the circular muscle of the human colon. Irving HR, Tan YY, Tochon-Danguy N, Liu H, Chetty N, Desmond PV, Pouton CW, Coupar IM. Life Sci; 2007 Mar 06; 80(13):1198-205. PubMed ID: 17258778 [Abstract] [Full Text] [Related]
16. General pharmacology of recombinant human basic fibroblast growth factor. Okumura M, Yajima M, Nishimura T, Ikeda H, Nishimori T. Arzneimittelforschung; 1996 Jul 06; 46(7):727-39. PubMed ID: 8842346 [Abstract] [Full Text] [Related]
17. Involvement of nitric oxide in fading of 5-hydroxytryptamine-induced vasocontraction in rat isolated vena portae smooth muscle. Datté JY, Offoumou MA. J Pharm Pharm Sci; 2004 Jan 23; 7(1):1-7. PubMed ID: 15144728 [Abstract] [Full Text] [Related]